Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Heart Disease: A Textbook of Cardiovascular Medicine.

1984 • 4,239 citations

Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease

2001 • 1,132 citations

A Comparison of Angioplasty with Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease

1992 • 738 citations

Exercise Treadmill Score for Predicting Prognosis in Coronary Artery Disease

1987 • 674 citations

Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic Angina<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2004 • 657 citations

RELATION BETWEEN SERUM-FREE-FATTY-ACIDS AND ARRHYTHMIAS AND DEATH AFTER ACUTE MYOCARDIAL INFARCTION

1968 • 534 citations

Metabolic Modulation of Acute Myocardial Infarction

1998 • 533 citations

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

1994 • 528 citations

Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction

1962 • 510 citations

Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial Infarction

1997 • 475 citations

MICROSURGICAL TUBOCORNUAL ANASTOMOSIS FOR REVERSAL OF STERILISATION

1977 • 426 citations

Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy

2003 • 360 citations

Ranolazine Stimulates Glucose Oxidation in Normoxic, Ischemic, and Reperfused Ischemic Rat Hearts

1996 • 292 citations

Multiple testing in clinical trials

1991 • 228 citations

INITIAL METABOLIC AND HORMONAL RESPONSE TO ACUTE MYOCARDIAL INFARCTION

1974 • 215 citations

Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.

1990 • 163 citations

A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents

1999 • 154 citations

Ranolazine Increases Active Pyruvate Dehydrogenase in Perfused Normoxic Rat Hearts: Evidence for an Indirect Mechanism

1996 • 135 citations

Statistical Considerations for Multiplicity in Confirmatory Protocols

1996 • 108 citations

Effects of a New Metabolic Modulator, Ranolazine, on Exercise Tolerance in Angina Pectoris Patients Treated with β-Blocker or Diltiazem

1992 • 108 citations

Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

2002 • 100 citations

Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart

1994 • 97 citations

Intermittent Transdermal Nitroglycerin Therapy in Angina Pectoris

1995 • 85 citations

Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction

1981 • 84 citations

Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris

1999 • 84 citations

Metabolic responses of the heart in acute myocardial infarction in man

1978 • 82 citations

Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat

2001 • 76 citations

Protective effects of ranolazine in guinea‐pig hearts during low‐flow ischaemia and their association with increases in active pyruvate dehydrogenase

1993 • 74 citations

Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion

1990 • 50 citations

Surgical management of acute and chronic cardiac mechanical complications due to myocardial infarction

1981 • 41 citations

Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris

1994 • 36 citations

Protective Effects of Ranolazine, a Novel Anti-ischemic Drug, on the Hydrogen Peroxide-Induced Derangements in Isolated, Perfused Rat Heart: Comparison With Dichloroacetate

1998 • 36 citations

Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit Heart

1996 • 32 citations

Effectiveness of three different doses of carvedilol for exertional angina

1998 • 24 citations

The effects of the novel anti-anginal agent RS 43285 on [lactic acid], [K+] and pH in a canine model of transient myocardial ischaemia

1987 • 21 citations

Application of computerized exercise ECG digitization

1992 • 17 citations

A DOUBLE‐BLIND TRIAL OF PERHEXILINE MALEATE IN THE PROPHYLAXIS OF ANGINA PECTORIS

1962 • 17 citations

Antianginal Effects of Ranolazine in Various Experimental Models of Angina

2011 • 13 citations

Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID

1995 • 4 citations